QwikZyme SARS-CoV-2 Clinical Evaluation
Study code
NBR108
Lead researcher
Professor Molly Stevens
Study type
Samples and data
Institution or company
Imperial College London
Researcher type
Commercial
Speciality area
Infection, COVID
Summary
The study involved the collection and assessment of patient saliva and anterior nasal samples to evaluate the performance of a prototype SARS-CoV-2 lateral flow diagnostic assay. The data collected was used to improve and further develop the test in order to meet the high performance required for a reliable rapid antigen test. This data collected was invaluable in our understanding of the requirements when working with varying patient sample matrices and will act as a platform in the development of higher performance diagnostic tests.
We are very grateful to the individuals who provided samples and information to enable us to undertake this work.
Participation: For this study, 36 participants from the COVID-19 BioResource took part by providing a small blood and saliva sample.
Organisation: This study is organised by Professor Molly Stevens from the Royal School of Mines Imperial College London